Abstract:Recent advances in microfluidics-based point-of-care testing (POCT) technology such as paper, array, and beads have shown promising results for diagnosing various infectious diseases. The fast and timely detection of viral infection has proven to be a critical step for deciding the therapeutic outcome in the current COVID-19 pandemic, which in turn not only enhances the patient survival rate but also reduces the disease-associated comorbidities. In the present scenario, rapid, noninvasive detection of the virus using low cost and high throughput microfluidics-based POCT devices embraces the advantages over existing diagnostic technologies, for which a centralized lab facility, expensive instruments, sample pretreatment, and skilled personnel are required. Microfluidic-based multiplexed POCT devices can be a boon for clinical diagnosis in developing countries that lacks a centralized health care system and resources. The microfluidic devices can be used for disease diagnosis and exploited for the development and testing of drug efficacy for disease treatment in model systems. The havoc created by the second wave of COVID-19 led several countries' governments to the back front. The lack of diagnostic kits, medical devices, and human resources created a huge demand for a technology that can be remotely operated with single touch and data that can be analyzed on a phone. Recent advancements in information technology and the use of smartphones led to a paradigm shift in the development of diagnostic devices, which can be explored to deal with the current pandemic situation. This review sheds light on various approaches for the development of cost-effective microfluidics POCT devices. The successfully used microfluidic devices for COVID-19 detection under clinical settings along with their pros and cons have been discussed here. Further, the integration of microfluidic devices with smartphones and wireless network systems using the Internet-of-things will enable readers for manufacturing advanced POCT devices for remote disease management in low resource settings.

A comprehensive look at the current and future technologies suitable for at home detection and management of viruses and virus causing diseases, Part I: point of care detection technologies

Point-of-Care Diagnostics of COVID-19: From Current Work to Future Perspectives

Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution

Point of care detection of COVID-19: Advancement in biosensing and diagnostic methods

Electrochemical SARS-CoV-2 Sensing at Point-of-Care and Artificial Intelligence for Intelligent COVID-19 Management

Low-Cost Biosensor Technologies for Rapid Detection of COVID-19 and Future Pandemics

Recent advances in point-of-care testing of COVID-19

Opportunities and Challenges for Biosensors and Nanoscale Analytical Tools for Pandemics: COVID-19

A Review on Potential Electrochemical Point-of-Care Tests Targeting Pandemic Infectious Disease Detection: COVID-19 as a Reference

Role of Technology in Detection of COVID-19

Nano-enabled biosensing systems for intelligent healthcare: towards COVID-19 management

Point-of-care diagnostics for infectious diseases: From methods to devices

Electrochemical investigations for COVID-19 detection-A comparison with other viral detection methods

Microfluidic Device-Based Virus Detection and Quantification in Future Diagnostic Research: Lessons from the COVID-19 Pandemic

Micro/nano biomedical devices for point-of-care diagnosis of infectious respiratory diseases

The perspectives of biomarker-based electrochemical immunosensors, artificial intelligence and the Internet of Medical Things toward COVID-19 diagnosis and management

Virus Detection: From State‐of‐the‐Art Laboratories to Smartphone‐Based Point‐of‐Care Testing

Facile biosensors for rapid detection of COVID-19

Trends in nanomaterial-based biosensors for viral detection

Nanobiosensor-based diagnostic tools in viral infections: Special emphasis on Covid-19

Miniaturized MXene-based electrochemical biosensors for virus detection